Home > Healthcare > Medical Devices > Surgical Devices > Critical Limb Ischemia Treatment (CLI) Market

Critical Limb Ischemia Treatment (CLI) Market Size

Report ID: GMI10560
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Critical Limb Ischemia Treatment Market Size

Critical Limb Ischemia Treatment Market size was valued at USD 4.2 billion in 2023 and is anticipated to witness growth at a CAGR of 6.7% from 2024 to 2032, driven by the increasing prevalence of peripheral artery disease (PAD) coupled with growing awareness and early diagnosis.

Critical Limb Ischemia Treatment Market

To get key market trends

Download Free Sample

The surge in PAD cases is primarily linked to the rising prevalence of risk factors such as diabetes, hypertension, smoking, and hyperlipidemia. For instance, according to the Centers for Disease Control and Prevention, in 2024, approximately 6.5 million people in the U.S. 40 or older were estimated to have PAD. Additionally, aging populations, where PAD is more prevalent, further drive up its rates. Given that PAD often precedes more severe conditions like CLI, the demand for effective treatments has never been more urgent.

Critical Limb Ischemia Treatment Market Report Attributes
Report Attribute	Details
Base Year:	2023
Critical Limb Ischemia Treatment Market Size in 2023:	USD 4.2 Billion
Forecast Period:	2024-2032
Forecast Period 2024-2032 CAGR:	6.7%
2032 Value Projection:	USD 7.4 Billion
Historical Data for:	2021-2023
No. of Pages:	110
Tables, Charts & Figures:	215
Segments covered:	Treatment Type, End-use, and Region
Growth Drivers:	Increasing prevalence of peripheral artery disease (PAD) Technological advancements in revascularization procedures Growing awareness and early diagnosis
Pitfalls & Challenges:	High cost of advanced treatments

Learn more about the key segments shaping this market

Download Free Sample

Furthermore, this growing patient population drives the demand for advanced CLI treatment options, including revascularization procedures, pharmacotherapy, and wound care solutions. The heightened awareness of PAD and its complications among healthcare providers and patients has led to earlier diagnosis and intervention, further boosting the market for CLI treatments. As PAD continues to affect millions worldwide, the CLI treatment market is expected to expand, driven by the need for innovative therapies and comprehensive management strategies.

Critical limb ischemia treatment refers to a range of medical and surgical interventions designed to restore blood flow to the affected limb, alleviate pain, and prevent limb loss in patients with critical limb ischemia (CLI).

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The CLI industry was valued at USD 4.2 billion in 2023 and is anticipated to witness a CAGR of 6.7% through 2032, driven by the increasing prevalence of peripheral artery disease (PAD) coupled with growing awareness and early diagnosis.

The hospitals segment is anticipated to record a CAGR of 7% over 2024-2032, as this setting offers comprehensive care for CLI patients, including initial diagnosis, imaging, surgical interventions, and post-operative care.

North America critical limb ischemia treatment market size in 2023 was valued at USD 1.7 billion and is predicted to record a CAGR of 6.1% through 2032, attributed to the well-developed healthcare system, which provides broad access to advanced diagnostic and therapeutic technologies.

Boston Scientific, Cesca Therapeutics, Cook Medical, Eli Lilly and Company, Medtronic plc, Micro Medical Solutions, Pfizer, Sanofi, and Terumo Corporation among others.